Want to see HK:9989 full AI Analyst Report?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Income Statement
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Income Statement
Last quarter (Q3 2026), Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total revenue was $1.22B, a decrease of 11.60% from the same quarter last year. In Q3, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's net income was $118.61M. See Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 5.48B | $ 5.28B | $ 5.45B | $ 7.16B | $ 6.37B | |
| $ 1.74B | $ 1.76B | $ 1.80B | $ 2.33B | $ 2.03B | |
| $ 1.11B | $ 1.01B | $ 2.66B | $ 1.21B | $ 1.07B | |
| Depreciation and Amortization | $ 372.91M | $ 331.05M | $ 373.60M | $ 307.66M | $ 302.74M |
| $ 846.59M | $ 1.20B | ― | $ 1.37B | $ 726.64M | |
| $ 635.97M | $ 741.31M | $ -238.11M | $ 1.14B | $ 773.20M | |
| $ -233.73M | $ -15.08M | ― | $ -168.70M | $ -611.27M | |
| $ 402.24M | $ 726.23M | ― | $ 829.85M | $ 222.26M | |
| $ 349.49M | $ 646.74M | ― | $ 727.43M | $ 240.79M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.24 | $ 0.44 | $ -0.53 | $ 0.50 | $ 0.16 |
| Diluted EPS | $ 0.24 | $ 0.44 | $ -0.53 | $ 0.50 | $ 0.16 |
| Weighted Average Shares Outstanding | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B |
| Weighted Average Shares Outstanding (Diluted) | 1.47B | 1.47B | 1.47B | 1.47B | 1.47B |
Currency in CNY
